Peptide-based vaccines for cancer: realizing their potential. - Wikidata - wikimedia - TriplyDB

Peptide-based vaccines for cancer: realizing their potential.

Peptide-based vaccines for cancer: realizing their potential.

http://www.wikidata.org/entity/Q37340462

about

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer Carrageenan as an adjuvant to enhance peptide-based vaccine potency Current immunotherapeutic approaches in pancreatic cancer.Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy What is recent in pancreatic cancer immunotherapy?Orchestration of CD4 T cell epitope preferences after multipeptide immunization.Therapeutic vaccines and cancer: focus on DPX-0907.Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.Discovery of Peptide Drugs from Natural Sources

P2860

Q26744827-A2357A26-E7F1-469D-A6FF-74D34BC59A12 Q26749451-8800BB38-110E-4B24-B374-8F13A9CB5E47 Q34012257-7A5C39C1-32FF-454B-8EA5-CCD49107E220 Q35212837-6E244630-A659-4656-8046-FEF863B0CBD8 Q35886496-77F92DAB-6C83-490E-B51D-541E07AB9372 Q36665335-CF4F17C1-B00A-4E84-A633-CC4C1EB15DB7 Q37092152-878329A1-BA13-45AD-B58D-6DC2984A7349 Q38193430-8B2ECD24-167A-4C24-9C1C-8C0E840A2301 Q38350670-E8E60056-F990-4754-85E8-7CC6852E7B6F Q59286551-4D7AD2CD-45E4-4ED5-9A27-D378BB0D714E

P2860

Peptide-based vaccines for cancer: realizing their potential.

http://www.wikidata.org/entity/Q37340462

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Peptide-based vaccines for cancer: realizing their potential.

@en

Peptide-based vaccines for cancer: realizing their potential.

@nl

type

label

Peptide-based vaccines for cancer: realizing their potential.

@en

Peptide-based vaccines for cancer: realizing their potential.

@nl

prefLabel

Peptide-based vaccines for cancer: realizing their potential.

@en

Peptide-based vaccines for cancer: realizing their potential.

@nl

P1433

Q37340462-6E769887-D731-4565-A749-8F3535F49E69

P1476

Q37340462-40F2D3EF-50B6-4C15-8FAD-9F258F6F839D

P2093

Q37340462-CCFDA253-F2D0-482C-AAE2-24EF5BC6073F

Q37340462-E0A878CE-D919-4FD9-AC40-71D06EA5FBCB

P2860

Q37340462-008791A6-F7AB-4246-BA77-B38237D4F13D

Q37340462-020DFFE3-F70A-4E9B-8064-006F56CEB944

Q37340462-063FDB7A-EB08-4C04-A756-9B6F91B5775C

Q37340462-06454A1A-030F-4526-B7C0-1CAB89A4A679

Q37340462-080FB120-BED4-40CE-8B95-31048756BA30

Q37340462-096444DA-2D96-4801-B279-8555BBC7A318

Q37340462-0BBDE1EA-3451-4DCF-B239-EBD0B2EAC31A

Q37340462-0EE43AF9-E394-483B-A29D-7048141EFD43

Q37340462-0F89BA9E-65F5-4AFC-8B7D-6808EDDEB1B5

Q37340462-0FBE7D8B-D8E1-4BA6-A7E8-3CA7ADAB0DDB

P304

Q37340462-B56C9B27-AA0B-4F6F-A0F4-1F03AF53E2BF

P31

Q37340462-4EDCD728-64A0-4EE0-AAE7-86C02A2D7AA2

P356

Q37340462-4554A55D-FF2D-443E-8BF4-3627619B9F2D

P433

Q37340462-A65C8798-95AD-441F-8E3C-46C1A60EF1BC

P478

Q37340462-DE533AF3-B3E3-4257-BB97-C85D99627AC4

P577

Q37340462-454E5395-0895-40BD-B88C-2633860712AE

P698

Q37340462-BDAD4638-241E-4D55-AEBF-965CAF884D5B

P356

14760584.7.10.1533

P1433

Expert Review of Vaccines

P1476

Peptide-based vaccines for cancer: realizing their potential.

@en

P2093

Shreya Kanodia

http://www.w3.org/2001/XMLSchema#string

W Martin Kast

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL

Recognition of tumor glycans by antigen-presenting cells

NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence

Taking dendritic cells into medicine

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry.

P304

1533-1545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.7.10.1533

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19053209

http://www.w3.org/2001/XMLSchema#string